For these reasons, conditioning recipients of
allogenic ES cell - derived HPCs could potentially be safer and less rigorous than conditioning recipients of bone marrow cells.
Not exact matches
Although a number of groups have already looked at the engraftment of
ES - derived HPCs in Rag2 − / − γc − / − mice, there are no reports on HPC engraftment in either syngeneic or
allogenic immunocompetent mice.
Our data show, for the first time, the efficacy of
ES - derived CD45 + HPCs to engraft in
allogenic recipients without the use of immunosuppressive agents, there by protecting cardiac allografts from rejection.
In addition to the high degree of pluripotency,
ES cells can generate newly - differentiated cells that appear to have low immunogenicity, an ideal property for
allogenic transplantation.